Trade Summary

2 days ago, Baynes Roy D., serving as Dir at Travere Therapeutics, Inc. (TVTX), sold 4,500 shares at $46.65 per share, for a total transaction value of $209,925.00. Following this transaction, Baynes Roy D. now holds 37,500 shares of TVTX.

This sale represents a 11.00% decrease in Baynes Roy D.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 5, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, 1 day after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.